Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 563

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma

Open access
Hu-Lieskovan, Siwen, Mok, Stephen, Homet Moreno, Blanca, Tsoi, Jennifer, Robert, Lidia, Goedert, Lucas, Pinheiro, Elaine M., Koya, Richard C., Graeber, Thomas G., Comin-Anduix, Begoña, Ribas, Antoni·2015·Science Translational Medicine

Abstract

MEK inhibition enhanced the antitumor activity of combined BRAF inhibition and immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaa4691

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 44 references

Cited by

See all 563

Metadata

Authors
Hu-Lieskovan, S., Mok, S., Homet Moreno, B., Tsoi, J., Robert, L., Goedert, L., Pinheiro, E. M., Koya, R. C., Graeber, T. G., Comin-Anduix, B., & Ribas, A.
Venue
Science Translational Medicine
Published
2015-03-18
Volume
7
Issue
279
Pages
279ra41-279ra41
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2099044540
Cited by
563
References
44
FWCI
23.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma. https://app.cochat.ai/papers/10.1126/scitranslmed.aaa4691
The paper
Hu-Lieskovan, S., Mok, S., Homet Moreno, B., Tsoi, J., Robert, L., Goedert, L., Pinheiro, E. M., Koya, R. C., Graeber, T. G., Comin-Anduix, B., & Ribas, A. (2015). Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaa4691

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.